Scientists dig into why mantle cell lymphoma beats First-Line therapy
NCT ID NCT04882475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines stored tissue samples from 160 adults with mantle cell lymphoma whose cancer returned or didn't respond after initial chemotherapy and rituximab. Researchers will analyze the samples to identify genetic and cellular features linked to treatment resistance. The goal is to gather knowledge that could guide future therapies, but no new treatments are given to participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MANTLE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
A.O. S. Croce e Carle
Cuneo, 12100, Italy
-
A.O.U. Citta della Salute e della Scienza di Torino- Ematologia Universitaria
Torino, Italy
-
AOU Integrata di Verona - U.O. Ematologia
Verona, 37134, Italy
-
AOU Maggiore della Carità di Novara - SCDU Ematologia
Novara, 28100, Italy
-
AOU Senese - U.O.C. Ematologia
Siena, SI, 53100, Italy
-
AOU di Padova - Ematologia
Padova, 35121, Italy
-
ASST Grande Ospedale Metropolitano Niguarda
Milan, MI, 20162, Italy
-
ASST Spedali Civili di Brescia - Ematologia
Brescia, Italy
-
Azienda Ospedaliera Universitaria Careggi- Unità funzionale di ematologia
Florence, 50134, Italy
-
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - SOC Clinica Ematologica
Udine, Italy
-
Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
Trieste, Italy
-
Azienda Unitа Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia - Ematologia
Reggio Emilia, Italy
-
Centro Riferimento Oncologico - S.O.C. Oncologia Medica A
Aviano, Italy
-
Ospedale Ca' Foncello - S.C di Ematologia
Treviso, Italy
-
Ospedale Guglielmo da Saliceto - U.O.Ematologia
Piacenza, 29121, Italy
-
ULSS 8 Berica - Ospedale S. Bortolo - Ematologia
Vicenza, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Engineered immune cells take aim at Hard-to-Treat lymphomas
- Can donor immune cells be engineered to fight blood cancer?
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Can a targeted drug boost standard chemo for a rare blood cancer?
- Smartwatches track hidden heart risk in blood cancer patients